Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Collaborative Research and Development Grants

University of Guelph

$127,029.00

Penicillium and Fusarium mycotoxin assessment using bovine intestinal epithelial cells (IEC) and co-cultured IEC + macrophages, and remediation with yeast mycotoxin binders

FY 2019-20

Summary
Mycotoxins are toxic metabolites from mold that commonly contaminate cereal and livestock feed crops around the world. The consumption of mycotoxins contributes to substantial economic losses to the livestock industry due to reduced productivity and health. There are over 500 different classes of mycotoxins, many of which have unknown mechanisms of action (MOA), and they are frequently found as mixture contaminants. Adding mycotoxin binders to livestock feeds (i.e. Alltech's yeast-based Mycosorb A+®) is an important remediation strategy for reducing risk of mycotoxicosis, since they can reduce bioavailability of certain mycotoxins, which reduces absorption across the gut epithelium. Alltech continues to modify its' yeast-based product with the hope of improving and diversifying mycotoxin binding efficacy, and these next generation binders need to be evaluated. When testing the toxicity of mycotoxins in different species, and the efficacy of Mycosorb A+® and new generation variants for reducing mycotoxin bioavailability, in vitro studies are critical for initial screening. We have demonstrated the utility of a bovine macrophage cell line (BoMAC) for carrying out such studies; however, BoMACs alone do not morphologically reflect the intestinal barrier where most mycotoxin exposure occurs. It is physiologically more relevant to carry out in vitro exposure studies using intestinal epithelial cells (IEC), or even better, co-cultured IEC + macrophages (IEC+BoMAC). The proposed study will use bovine IECs and co-cultured IEC+BoMAC to explore the impact of mycotoxin exposure on the intestinal barrier, and to assess the efficacy of the mycotoxin binder Mycosorb A+® or new generation variants for reducing mycotoxin bioavailability.
Program
Collaborative Research and Development Grants
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
532378-2018
Name nom
Karrow, Niel
Department département
Animal Biosciences
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2019
Competition year année de concours
2018
Award amount
127029
Program id
CRDPJ
Program name en
Collaborative Research and Development Grants
Program name fr
Subventions de recherche et développement coopérative
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
101
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Animal production and animal primary products
Area of application fr
Production animale et produits animaux primaires
Research subject code
5500
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Animal biology
Research subject fr
Biologie animale
Installment
inst:1 - 2
Partie
1
Nb partie
2
Application title
Penicillium and Fusarium mycotoxin assessment using bovine intestinal epithelial cells (IEC) and co-cultured IEC + macrophages, and remediation with yeast mycotoxin binders
Keyword
NSERC
Application summary
Mycotoxins are toxic metabolites from mold that commonly contaminate cereal and livestock feed crops around the world. The consumption of mycotoxins contributes to substantial economic losses to the livestock industry due to reduced productivity and health. There are over 500 different classes of mycotoxins, many of which have unknown mechanisms of action (MOA), and they are frequently found as mixture contaminants. Adding mycotoxin binders to livestock feeds (i.e. Alltech's yeast-based Mycosorb A+®) is an important remediation strategy for reducing risk of mycotoxicosis, since they can reduce bioavailability of certain mycotoxins, which reduces absorption across the gut epithelium. Alltech continues to modify its' yeast-based product with the hope of improving and diversifying mycotoxin binding efficacy, and these next generation binders need to be evaluated. When testing the toxicity of mycotoxins in different species, and the efficacy of Mycosorb A+® and new generation variants for reducing mycotoxin bioavailability, in vitro studies are critical for initial screening. We have demonstrated the utility of a bovine macrophage cell line (BoMAC) for carrying out such studies; however, BoMACs alone do not morphologically reflect the intestinal barrier where most mycotoxin exposure occurs. It is physiologically more relevant to carry out in vitro exposure studies using intestinal epithelial cells (IEC), or even better, co-cultured IEC + macrophages (IEC+BoMAC). The proposed study will use bovine IECs and co-cultured IEC+BoMAC to explore the impact of mycotoxin exposure on the intestinal barrier, and to assess the efficacy of the mycotoxin binder Mycosorb A+® or new generation variants for reducing mycotoxin bioavailability.
University of Guelph - $127,029 Grant (2019-20) | Canada Spends